diperodon

0 marketed 1 in Phase 2

This page covers all diperodon drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

Patent intelligence